MedPath

A Clinical Trial to Evaluate the Effects of an Eye Serum on Improving the Appearance of the Periorbital Area

Not Applicable
Completed
Conditions
Periorbital Area
Interventions
Other: DIME Beauty Luminosity Eye Serum
Registration Number
NCT06143033
Lead Sponsor
Dime Beauty Co.
Brief Summary

This study will evaluate the efficacy of the DIME Beauty Luminosity Eye Serum in improving the appearance of skin in the periorbital eye area. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use the test products. Participants will be required to complete questionnaires at Baseline, Day 30, and Day 60, photos will be taken at Baseline, Day 30, and Day 60, and expert skin grading will take place at Baseline and Day 60.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
35
Inclusion Criteria
  • Females age 18-65.
  • Have visible dark circles under the eyes.
  • Have puffy eyes.
  • Have bags under the eyes.
  • Have visible fine lines and wrinkles around the eyes.
  • Have a smartphone or camera to take before-and-after selfies.
Exclusion Criteria
  • Anyone not in good health.
  • Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
  • Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
  • Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months.
  • Anyone who cannot/ will not commit to the study protocol.
  • Anyone with a history of substance abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DIME Beauty Luminosity Eye SerumDIME Beauty Luminosity Eye SerumParticipants will use the serum twice daily after their morning and evening skincare routine (i.e., after cleansing, and applying facial serums and moisturizers), but before the application of sunscreen.
Primary Outcome Measures
NameTimeMethod
Change in appearance of periorbital puffiness. [Baseline to Day 60]60 days

Measured via expert skin grading of before \& after photos conducted by a board-certified dermatologist.

Change in participants' perception of the appearance of dark circles underneath eyes. [Baseline to Day 60]60 days

Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Change in participants' perception of the appearance of periorbital puffiness. [Baseline to Day 60]60 days

Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Change in appearance of dark circles underneath eyes. [Baseline to Day 60]60 days

Measured via expert skin grading of before \& after photos conducted by a board-certified dermatologist.

Secondary Outcome Measures
NameTimeMethod
Change in appearance of fine lines and wrinkles in the eye area. [Baseline to Day 60]60 days

Measured via expert skin grading of before \& after photos conducted by a board-certified dermatologist.

Change in participants' perception of the appearance of fine lines and wrinkles in the eye area. [Baseline to Day 60]60 days

Measured via study-specific surveys. Surveys will be completed by participants and are designed using a 5-point Likert scale, with th 5 representing the most favorable/best outcome (e.g., "Not at all") and 1 representing the least favorable/worst outcome (e.g., "Severe").

Trial Locations

Locations (1)

Citruslabs

🇺🇸

Santa Monica, California, United States

© Copyright 2025. All Rights Reserved by MedPath